MedTrace Logo

Epidemiology and Determinants of Outcomes of Hospital Acquired Blood Stream Infections in the Intensive Care in Turkey

NCT04304456 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 810

Last updated 2020-03-11

No results posted yet for this study

Summary

In this observational study, it is aimed to investigate the mortality and morbidity rates of hospital-acquired blood stream infections that are treated in intensive care units (ICU). The effects of properties of the micro-organism such as type and antimicrobial resistance on the infection and its outcomes will be mainly explored. In addition, the impact of antibiotic options and other treatment modalities on survival of patients will be investigated. Twenty-seven different ICUs from Turkey will be included in this study.

Conditions

  • Bacteremia
  • Sepsis
  • Hospital Acquired Condition

Interventions

OTHER

Treatment

Antimicrobial and other treatment modalities such as source control, vasoactive medications, dialysis

Sponsors & Collaborators

  • European Society of Intensive Care Medicine

    collaborator OTHER

  • SCARE (Study group for carbapenem resistance)

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-30
Primary Completion
2021-09-30
Completion
2022-04-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04304456 on ClinicalTrials.gov